Moreadith et al., Journal of Molecular Medicine, vol. 75 pp. 208-216, 1997.* |
Moens et al., Development, vol. 119, pp. 485-499, 1993.* |
Seamark, Reproduction, Fertility and Development, vol. 6, No. 5, pp. 653-657, 1994.* |
Mullins et al., Journal of Clinical Investigations, vol. 998, No. 11, pp. S37-S40, 1996.* |
Hammer et al., Journal of Animal Science, vol. 63 pp. 269-278, 1986.* |
Ebert et al., Molecular Endocrinology, vol. 2, pp. 277-283, 1988.* |
Wall, Theriogenology, vol. 45, pp. 57-68, 1996.* |
Kappel et al., Current Opinion in Biotechnology, vol. 3, pp. 548-553, 1992.* |
Strojek & Wagner, Genetic Engineering: Principles and Methods, vol. 10, pp. 211-246, 1988.* |
Pearson, B.E. and Choi, T.K., “Expression of the human β-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice,” Proc. Natl. Acad. Sci., USA, 90:10578-10582 (1993). |
Yamaguchi, F., et al., “Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory”, NeuroReport, 2:781-784 (1991). |
Kammesheidt, A., et al., “Deposition of β/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain”, Proc. Natl. Acad. Sci., USA, 89:10857-10861 (1992). |
Aguzzi, A., et al., “Transgenic and Knock-Out Mice: Models of Neurological Disease”, Brain Pathology, 4:3-20 (1994). |
Kawabata, S., et al., “Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein”, Nature, 354:476-478 (1991). |
Delacourte, A., et al., “Towards the development of an in vitro study model of Alzheimer-type neurofibrillary degeneration”, Press Méd., 19:170-173 (1990). |
Kawabata, S., et al., “Alzheimer's retraction”, Nature, 356:23 (1992). |
Quon, D., et al., “Formation of β-amyloid protein deposits in brains of transgenic mice”, Nature, 352:239-241 (1991). |
Lamb, B.T., et al., “Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice”, Nature Genetics, 5:22-30 (1993). |
Billingsley, M.L., et al., “Calcineurin Immunoreactivity in Alzheimer's Disease”, Exper. Neur.. 126:178-184 (1994). |
Hashimoto, Y. and Soderling, T.R., “Regulation of Calciuneurin by Phosphorylation”. J. of Biol. Chem., 264(28):16524-16529 (1998). |
Ferreira, A., et al., “Calcineurin Is Associated with the Cytoaskeleton of Cultured Neurons and Has a role in the Acquisition of Polarity”, Mol. Biol. Cell, 4:1225-1238 (1993). |
Schorderet, M., “Alzheimer's disease: fundamental and therapeutic aspects”, Experientia, 51:99-105 Birkhäuser Verlag, CH-4010 Base/Switzerland (1995). |
Drewes, G., et al., “Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcineurin and phosphatase-2A”, FEBS Letters, 336(3):425-432 (1993). |
Goto, S., et al., “Dephosphorylation of Microtubule-Associated Protein 2, τ Factor, and Tubulin by Calcineurin,” J. Neurochem., 45(1):276-283 (1985). |
Gong, C.-X., et al., “Alzheimer's Disease Abnornally Phosphorylated τ Is Deophosphorylated by Protein Phosphatase-2B (Calcineurin)”, J. Neurochem., 62(2):803-806 (1994). |
Martensen, T.M., et al., “Identification of the Site on Calcineurin Phosphorylated by Ca2+/CaM-Dependent Kinase II: Modification of the CaM-Binding Domain”, Biochemistry, 28(24):9243-9247 (1989). |
Kuno, T., et al., “Distinct Cellular Expression of Calcineurin Aα and Aβ in Rat Brain”, J. Neurochem., 58(5):1643-1651 (1992). |
Sandhu, F.A. et al., “Expression of the human B-amyloid protein of Alzheimer's disease specifically in the brains of transgenic mice”, J. Biol. Chem., 266(32):21331-21334 (1991). |
Gong, C.-X. et al., “Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A”, Neurosci. (Oxford), 61(4):765-72 (1994). |
Kincaid, R.L., et al., “Cloning and Characterization of Molecular Isoforms of the Catalytic Subunit of Calcineurin Using Nonisotopic Methods”, J. Biol. Chem,, 265(19):11312-11319 (1990). |
Games, D., et al., “Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein”, Nature, 373:523. |
Bradley, A., et al., “Modifying the Mouse: Design and Desire”, Biotech., 10:534-539 (1992). |
Capecchi, M.R., “Targeted Gene Replacement”, Scientific Amer. 270(3):34-41 (1994). |
Götz, J., et al., “Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform”, EMBO J., 14(7):1304-1313 (1995). |
Kincaid, R.L., “Calcineurin as a pivotal Ca2+-sensitive switching element in biological responses: Implications for the regulation of tau phosphorylation in Alzheimer's disease.” in Alzheimer's Disease: Lessons from Cell Biology, Kosik et al., eds. (Berlin: Springer-Verlag), pp. 88-102 (1995). |